What is the appropriate management for a patient with traumatic head injury and brain swelling after a piece of brain is removed and stored in a sterile solution?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Decompressive Craniectomy with Bone Flap Storage

After decompressive craniectomy for traumatic brain injury with severe swelling, the removed bone flap should be stored either cryopreserved at -70°C to -80°C in a sterile bone bank or placed subcutaneously in the patient's abdominal wall, with reimplantation typically performed 6-12 weeks later once brain swelling has resolved and the patient is medically stable.

Immediate Post-Craniectomy Management

Intracranial Pressure and Cerebral Perfusion

  • Maintain cerebral perfusion pressure (CPP) between 60-70 mmHg to optimize outcomes while avoiding complications of both hypoperfusion and excessive pressure 1
  • Monitor ICP continuously after decompressive craniectomy, as retrospective studies demonstrate benefits of postoperative ICP monitoring following this procedure 1
  • Be vigilant for secondary ICP increases due to reperfusion bleeding, new extra-axial collections, or increased brain edema after decompression 1

Osmotherapy for Intracranial Hypertension

If signs of threatened intracranial hypertension or brain herniation develop:

  • Administer mannitol 20% or hypertonic saline at equiosmotic dose of 250 mOsm over 15-20 minutes 1
  • Both agents have comparable efficacy at equiosmotic doses for treating intracranial hypertension 1, 2
  • Mannitol dosing: 0.25-2 g/kg body weight as 15-25% solution over 30-60 minutes 3
  • Hypertonic saline: 7.5% at 250 mL per bolus over 15-20 minutes, targeting serum sodium 145-155 mmol/L 2

Choose hypertonic saline when: hypovolemia or hypotension is present 2

Choose mannitol when: hypernatremia already exists or improved cerebral oxygenation is the priority 2

Critical Monitoring Requirements

  • Monitor fluid, sodium, and chloride balances with both osmotic agents 1
  • Mannitol requires volume compensation due to osmotic diuresis 1, 2
  • Measure serum sodium within 6 hours of hypertonic saline bolus administration 2
  • Avoid serum osmolality exceeding 320 mOsm/L with mannitol 2
  • Avoid sodium levels exceeding 155-160 mmol/L with hypertonic saline 2

Fluid Management Strategy

Resuscitation Fluids

  • Use normal saline 0.9% as the crystalloid of choice - it is the only commonly available isotonic crystalloid by real osmolality that prevents increases in brain water 4
  • Ringer's lactate and Ringer's acetate are hypotonic by real osmolality and should be avoided as they can increase brain water content 4
  • Never use 4% albumin solution - it significantly increases mortality in severe TBI patients (24.5% vs. 15.1% with saline, RR: 1.62, p = 0.009) 5

Blood Pressure Management

  • After adequate fluid resuscitation, if hypotension persists, use small boluses of α-agonists (metaraminol or norepinephrine via central line) to maintain CPP 4
  • Target mean arterial pressure (MAP) ≥ 90 mmHg in patients with isolated TBI 1

Ventilation Management

Avoid Prolonged Hypocapnia

  • Do not use prolonged hypocapnia to treat intracranial hypertension - severe and prolonged hypocapnia (25 mmHg for 5 days) worsens neurological outcomes compared to normocapnia 1
  • Maintain PaCO2 at 4-5 kPa (approximately 30-38 mmHg) during transfer 1
  • Hypocapnia exacerbates secondary ischemic lesions by decreasing cerebral blood flow 1

Pediatric Considerations

For children with traumatic brain injury and decompressive craniectomy:

Age-Specific Blood Pressure Targets 1

  • < 3 months: MAP 40-60 mmHg
  • 3 months-1 year: MAP 45-75 mmHg
  • 1-5 years: MAP 50-90 mmHg
  • 6-11 years: MAP 60-90 mmHg
  • 12-14 years: MAP 65-95 mmHg

Special Pediatric Management

  • Consider hypertonic saline bolus (2.7-3%, 2-3 mL/kg) before intubation to prevent ICP rise during laryngoscopy 1
  • Children have less available space around the brain until age 20, making small volume changes more clinically significant 1
  • Monitor blood glucose closely as young children are more prone to hypoglycemia 1
  • Use isotonic saline with 5-10% glucose as maintenance fluid with 50-60% restriction on standard rates 1

Common Pitfalls to Avoid

Contraindicated Interventions

  • Never administer albumin solutions - this is associated with nearly doubled mortality at 2-year follow-up (41.8% vs. 22.2%, RR: 1.88, p < 0.001) 5
  • Avoid prophylactic osmotherapy in patients without documented intracranial hypertension - it provides no benefit over crystalloids 1, 2
  • Do not use hypertonic saline for volume resuscitation in hemorrhagic shock 2

Monitoring for Complications

  • Watch for intraoperative brain extrusion - a gradual and controlled decompression technique with multiple small dural openings can prevent massive brain swelling during surgery 6
  • Discontinue mannitol if renal, cardiac, or pulmonary status worsens 3
  • Be aware that mannitol is the only ICP-lowering therapy associated with improved cerebral oxygenation 1

Transfer Considerations

  • Ensure patient's trachea is intubated if GCS ≤ 8 before departure 1
  • Use capnography during transfer with all values maintained at 4-5 kPa 1
  • Discuss appropriate driving style with ambulance technicians, as acceleration causes hypotension and deceleration causes ICP spikes 1
  • Keep eyes open (not taped) to permit regular pupillary examination, using moisturizing drops to prevent corneal drying 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Traumatic Brain Injury with Hypertonic Saline and Mannitol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fluid Management in Traumatic Brain Injury

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evidence Against the Use of Albumin in Traumatic Brain Injury

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.